Business Wire

TEMENOS

15.1.2020 08:02:08 CET | Business Wire | Press release

Share
Temenos Reaches Major Milestone With the Roll-out of Temenos Transact Microservices Architecture, Enabling Large Banks to Strategically Transform Their Core Systems at Scale in a Safe and Progressive Manner
  • Larger banks can now renovate their core banking applications component by component without compromising their end goal of a full system transformation to a cloud-agnostic, cloud-native architecture. Temenos Transact microservices architecture enables continuous change with tangible business benefits at every stage.
  • Temenos Transact microservices - such as accounts and deposits, and retail lending - can be integrated through APIs in any sequence with any legacy infrastructure, quickly and safely, helping banks to unlock the power of digital transformation.
  • Temenos offers banks a real choice of transformation strategies, from continuous renovation where larger banks replace components of their architecture one at a time to ‘build and renovate’ - where they can build a new digital stack while continuously migrating products and customer bases from their legacy systems.
  • Temenos Transact microservices can deliver enterprise-wide capabilities such as pricing on top of legacy infrastructures as a first step toward creating value for the bank. For a complete digital banking transformation, Transact works in conjunction with microservices-based Temenos Infinity.
  • Temenos Transact is built on cloud-native, cloud-agnostic technology that enables banks to significantly reduce their total cost of ownership through elastic cloud scalability, distributed database technology and multi-cloud resilience, all underpinned by the benefits of vendor and platform independence

Temenos (SIX: TEMN), the banking software company, announced that it has reached a major milestone in the delivery of its microservices-based architecture for cloud-native, cloud-agnostic Temenos Transact. This unlocks the potential for Tier 1 banks to strategically transform their core banking systems at scale.

Large banks are burdened by their legacy infrastructures. The cost and associated risk of replacing these complex systems, which have been customized over decades, is high. However, these outdated systems are making banks suffer high operational costs, high risk of outages, and a lack of agility that prevents them from bringing innovative, personalized products to market. The urgency to digitally transform has never been greater.

Temenos is now accelerating the roll-out of its microservices to help larger banks continuously transform their core banking applications. Unlike traditional monolithic core banking systems, Temenos Transact has independently deployable components that support continuous renovation based on the bank’s business needs. For the first time, there is now an alternative for banks to safely update critical elements of their core banking systems one component at a time with proven cloud-native, cloud-agnostic software and see tangible benefits along the way. These microservices can be deployed independently, enterprise wide and banks can retain existing systems where they are fit for purpose. Combined with microservices-based Temenos Infinity, banks have an agile, services based architecture for both core banking and digital customer journeys. This offers an alternative to the already successful build and migrate implementation approach, where banks can build a new digital stack while continuously migrating products and customer bases from their legacy systems.

Banks can pursue a long-term strategic roadmap while continuously renovating product lines, such as deposits and accounts, and core systems such as funds authorization and position keeping, based on their commercial and operational priorities. This strategy enables banks to flex the sequence of renovation as priorities change over time.

Temenos’ microservices strategy offers existing Temenos Transact clients the benefit of granular upgrades, allowing them to react to market opportunities faster while cutting the total cost of ownership of their existing core banking platform. Leveraging Temenos Continuous Deployment , which extends the Temenos DevOps operations into banks’ own environments, Temenos clients can accelerate the speed of software delivery and rapidly bring competitive innovations to market.

For smaller banks, the recommended approach is to select Temenos Transact as a SaaS offering to speed deployment and simplify IT operations.

Building on its extensive set of standalone services - such as Payments, Financial Crime Mitigation, Enterprise Data Management and Analytics - Temenos now offers new standalone banking microservices including:

  • Accounts and Deposits: this service manages all the activities in the life of current, checking and deposit accounts in real time. Feature-rich, it supports any currency and offers a great variety of interest calculation methods and configurable business rules and events. Fully automated, the service integrates seamlessly through APIs with distribution services and other core systems such as payments, pricing, accounting. Deployed as a microservice, it leverages the cloud’s elastic scalability to manage millions of accounts with the lowest TCO.
  • Retail Lending: this service manages a wide range of lending products, from simple unsecured consumer loans in any currency to complex facilities including multiple loans and associated collateral requirements. Designed for real-time processing and highly configurable, Retail Lending is rich and flexible enough to replace a number of legacy systems within the bank. Through APIs, it will integrate with the rest of the IT ecosystem, in the cloud or on premise.
  • Enterprise product : a standalone product catalogue that enables banks to design and take to market products on a single system, reducing cost and boosting profitability of products. The service enables financial institutions to centralize all product definitions in a common repository, giving them greater overview and control across multiple business lines often working in silos. It helps banks launch new products and commercial offers much faster.
  • Enterprise pricing: a central pricing engine that supports greater personalization of products services driven by AI, and improves time to market for all product types, including bundled products, relationship-based pricing and third-party products. Banks can get greater control over the fees they apply, often within disconnected applications. This increases profitability for the banks. With relationship pricing, they are able to define granular rules based on the client’s characteristics and the context of a transaction, and thus offer a personalized banking experience to each customer.

Temenos Transact microservices are functionally rich, enabling fast deployment without the need to build additional capabilities on top. Temenos has created reusable country Model Banks, which include regulatory compliance and best business practice solutions, for more than 150 countries. This helps banks go live faster and acts as a foundation for future innovation.

Max Chuard, Chief Executive Officer, Temenos, said : "To date, larger banks have been shying away from digital transformation projects. As the #1 banking software company, we are taking the lead in bringing about industry change. We are delivering the Temenos Transact microservices architecture, which will revolutionize banking. This microservices-based cloud architecture enables large banks to finally unlock their potential by transforming their core banking applications rapidly and at scale. Larger banks can renovate their core banking applications without compromising their end goal of a full digital transformation to a cloud-agnostic, cloud-native architecture, one component at a time. This is an alternative to the already successful build and migrate approach where, banks can build a new digital stack while continuously migrating products and customer bases from their legacy systems.

"We have a proven track record of helping banks to digitally transformation. Our high-performing clients using Temenos software have achieved industry-leading cost-income ratios of 25.2% and returns on equity of 25.0%, 2X better than the industry average. Only Temenos has the advanced technology and depth of banking expertise and to deliver this."

Temenos Transact microservices leverage cloud-native, cloud-agnostic technology to improve efficiency by allowing banks to scale quickly and elastically while benefiting from multi-cloud resilience. Temenos gives banks freedom of choice to deploy software on premise, in any public cloud, or as a Temenos SaaS.

- Ends –

About Temenos
Temenos AG (SIX: TEMN), headquartered in Geneva, is the world’s leader in banking software, partnering with banks and other financial institutions to transform their businesses and stay ahead of a changing marketplace. Over 3,000 banks across the globe, including 41 of the top 50 banks, rely on Temenos to process both the daily transactions and client interactions of more than 500 million banking customers. Temenos offers cloud-native, cloud-agnostic front office and core banking, payments, fund management and wealth management software products enabling banks to deliver consistent, frictionless customer journeys and gain operational excellence.

Temenos software is proven to enable its top-performing clients to achieve industry-leading cost-income ratios of 25.2% and returns on equity of 25.0%, 2X better than the industry average. These clients also invest over 53% of their IT budget on growth and innovation versus maintenance, which is 2.5X the industry average, proving the banks’ IT investment is adding tangible value to their business.

For more information, please visit www.temenos.com .

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Westinghouse Celebrates Record-breaking 80 Years of Nuclear Fuel Manufacture at Springfields30.3.2026 14:00:00 CEST | Press release

Fuel manufactured at Springfields has generated enough energy to supply the UK’s electricity demand for 26 years, avoiding the emission of nearly 3 billion tonnes of CO2 The Westinghouse Springfields facility in Lancashire, UK, has marked a significant milestone as the oldest continuous nuclear fuel manufacturing site in the world, starting from its original license on the 28th, March 1946. The site was chosen by the UK Government to develop nuclear fuel for the world’s earliest civil nuclear power stations, as well as subsequent Magnox and Advanced Gas Reactors (AGR) reactors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330135973/en/ From left to right: Sophie Lemaire; Marc Chevrel; Rory O'Neill; Craig Boothby; and Robert Gofton, CEO at Nuclear Institute Across the last eight decades, the Springfields site has supported the UK nuclear fleet, manufacturing more than eight million AGR pins, sintering and pressing over 5

HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia (BPH)30.3.2026 14:00:00 CEST | Press release

HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced the successful treatments of the first patients in WOLVERINE, a prospective feasibility trial evaluating the Edison® Histotripsy System for the treatment of benign prostatic hyperplasia (BPH) at Prince of Wales Hospital in Hong Kong, a teaching hospital for The Chinese University of Hong Kong. The Edison System is a novel, non-invasive, image guided platform that uses the mechanical properties of focused ultrasound, called histotripsy, to destroy unwanted tissue without the need for invasive procedures, and with potentially fewer side effects than traditional, invasive therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330349844/en/ HistoSonics Non-Invasive Edison Histotripsy System. Image credit: HistoSonics WOLVERINE is a prospective, multi-center, single-arm feasibility trial designed to evaluate

Biocytogen Grants Taisho Pharmaceutical a License to its RenNano® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 13:00:00 CEST | Press release

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro

Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 13:00:00 CEST | Press release

Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a

Samsung Biologics Strike: Labor Union Warns of CDMO Supply Chain Risks Following Overwhelming Vote30.3.2026 11:52:00 CEST | Press release

Union members overwhelmingly approve strike action with 95.52% voting in favor on a 95.38% turnout, clearing the final legal hurdle after mediation ceased.Union emphasizes this is a fight against structural corporate governance issues, citing unresolved allegations concerning unfair labor practices and ESG compliance risks.Management adhered to a group-level wage guideline rather than bargaining on the basis of Samsung Biologics' own performance, exposing a lack of independent bargaining authority. The Samsung Biologics Labor Union (President: Jaesung Park), representing approximately 75% of the company's total employees, announced today that its members have overwhelmingly voted in favor of a strike, with 95.52% voting in favor on a 95.38% turnout during a voting period from March 24 to March 29. Following the Incheon Regional Labor Relations Commission's decision to cease mediation, the union has now secured the legal mandate to strike. The union stressed that this strike is not mere

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye